Last updated 14 days ago

A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

84 patients around the world
Available in United States, Brazil, Mexico
Bristol-Myers Squibb
84Patients around the world

This study is for people with

Arthritis
Rheumatoid arthritis

Requirements for the patient

To 65 Years
All Gender

Medical requirements

Adult participants with rheumatoid arthritis (RA) who meet definition of difficult-to-treat.
Juvenile arthritis or onset of inflammatory arthritis before age 18.
Seronegative RA participants in whom polymyalgia rheumatica has not been ruled out.
Active fibromyalgia with pain symptoms or signs that would interfere with joint assessment.
Other protocol-defined Inclusion/Exclusion criteria apply.
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloadsCareers
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy